基于CT影像组学列线图术前预测结直肠癌KRAS突变状态
回顾性纳入172例结直肠癌患者,按7:3随机分为训练组121例(KRAS突变阳性38.8%)和验证组51例(阳性39.2%),从门静脉期CT单层面和全容积感兴趣区提取影像组学特征构建2D和3D模型及临床-影像组学列线图;验证组AUC分别为0.75和0.84,整合列线图AUC为0.92,优于2D和3D影像组学模型(P<0.05)。
要点
- 门静脉期CT影像组学2D和3D模型均可预测结直肠癌KRAS突变,验证组AUC分别为0.75和0.84。
- 整合临床危险因素的列线图验证组AUC达0.92,优于2D和3D影像组学模型(P<0.05)。
- CT影像组学对结直肠癌KRAS状态显示满意诊断意义,临床联合模型可能用于术前个体化预测。
核心结论
- 2D和3D影像组学模型均可预测KRAS突变,整合列线图能更好地预测结直肠癌KRAS突变状态。
研究设计与样本
- 回顾性研究纳入172例结直肠癌患者,按7:3随机分为训练组121例(KRAS突变阳性38.8%)和验证组51例(阳性39.2%),从门静脉期CT单层面和全容积感兴趣区提取影像组学特征,采用LASSO构建影像组学标签、逻辑回归筛选变量建立临床-影像组学模型,以ROC、校准曲线和DCA评价。
诊断标准与关键数值
- 从单层面和全容积感兴趣区共提取1018个影像组学特征,2D和3D模型各保留8个特征;验证组AUC分别为2D模型0.75、3D模型0.84、整合列线图0.92,Delong检验显示整合列线图优于2D模型(P<0.05)和3D模型(P<0.05)。
临床应用与阅片要点
- 作者认为CT影像组学对结直肠癌KRAS状态显示满意诊断意义,临床联合模型可能用于KRAS突变的术前个体化预测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aimed to develop a model to predict KRAS mutations in colorectal cancer according to radiomic signatures based on CT and clinical risk factors.
METHODS: This retrospective study included 172 patients with colorectal cancer. All patients were randomized at a 7:3 ratio into a training cohort (n = 121, 38.8% positive for KRAS mutation) and a validation cohort (n = 51, 39.2% positive for KRAS mutation). Radiomics features were extracted from single-slice and full-volume regions of interest on the portal-venous CT images. The least absolute shrinkage and selection operator (LASSO) algorithm was adopted to construct a radiomics signature, and logistic regression was applied to select the significant variables to develop the clinical-radiomics model. The predictive performance was evaluated by receiver operating characteristic curve (ROC) analysis, calibration curve analysis, and decision curve analysis (DCA).
RESULTS: 1018 radiomics features were extracted from single-slice and full-volume ROIs. Eight features were retained to construct 2D (two-dimensional, 2D) radiomics model. Similarly, eight features were retained to construct 3D (three-dimensional, 3D) radiomics model. The area under the curve (AUC) values of the test cohort were 0.75 and 0.84, respectively. Delong test showed that the integrated nomogram (AUC = 0.92 in the test cohort) had better clinical predictive efficiency than 2D radiomics (p-value < 0.05) model and 3D radiomics model (p-value < 0.05).
CONCLUSION: The 2D and 3D radiomics models can both predict KRAS mutations. And, the integrated nomogram can be better applied to predict KRAS mutation status in colorectal cancer.
ADVANCES IN KNOWLEDGE: CT-based radiomics showed satisfactory diagnostic significance for the KRAS status in colorectal cancer, the clinical-combined model may be applied in the individual pre-operative prediction of KRAS mutation.
引用
- Xue, Peng, Chen, et al. Preoperative prediction of KRAS mutation status in colorectal cancer using a CT-based radiomics nomogram. Br J Radiol. 2022. PMID: 35312376. doi:10.1259/bjr.20211014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。